Law Firm · Petitioner PracticeVICP Petitioner PracticeLast verified
Cases filed
2
Comp rate
50%
Total awarded
$40K
Tenure
2021–2025
⚠Heads up: The case docket, statistics, and overview below are compiled from AI-extracted data. Specific figures (case counts, awards, outcomes) may contain errors. Verify with the firm directly or with source court records before relying on them.
Mast Law Firm is a U.S. law firm whose name appears on 2 petitions in the National Vaccine Injury Compensation Program. The firm's filings on file span 2021-2025, with a compensation rate of 50%. Cases on file have produced $40K in total awards. The attorneys appearing on this firm's docket include Nichole Glance Booker.
AI-generated overview · may contain errors. Verify details with the firm directly before relying on them.
Answers built from this firm's public case docket.
How do I find a good VICP lawyer?
Most petitioners hire counsel because the program's evidentiary burden, expert-witness requirements, and procedural rules are complex. Reasonable attorney fees in VICP cases are paid by the program — not by the petitioner — under 42 U.S.C. § 300aa-15(e)(1), so engaging counsel does not reduce a successful petitioner's recovery. You can submit a free inquiry → to have your case forwarded to attorneys with VICP experience, or research Mast Law Firm's case history below.
How many VICP cases has Mast Law Firm filed?
Mast Law Firm has filed 2 petitions in the U.S. Vaccine Injury Compensation Program with publicly-available decisions, between 2021 and 2025.
What is Mast Law Firm's compensation rate?
Mast Law Firm's overall compensation rate across 2 VICP cases is 50% (1 compensated).
How much has Mast Law Firm won in VICP cases?
Cases filed by Mast Law Firm have resulted in $40K in total compensation awards from the U.S. Vaccine Injury Compensation Program (visible-in-public-decisions only).
What kinds of vaccine injury cases does Mast Law Firm handle?
Based on the cases on file, Mast Law Firm's practice includes SIRVA (shoulder injury related to vaccine administration), Guillain-Barré Syndrome (GBS), among other vaccine-related conditions.